-
FDA Issues EUA to Yale School of Public Health for SalivaDirect COVID-19 Test
americanpharmaceuticalreview
August 20, 2020
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Yale School of Public Health for its SalivaDirect COVID-19 diagnostic test, which uses a new method of processing saliva samples when testing for COVID-19 infection
-
Luminex Receives EUA for COVID-19 Antibody Test
americanpharmaceuticalreview
July 27, 2020
Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's xMAP® SARS-CoV-2 Multi-Antigen IgG Assay.
-
Company Implements LabVantage COVID-19 LIMS Solution
contractpharma
July 24, 2020
LabVantage Solutions Inc. has announced that a Fortune 100 global consumer packaged goods (CPG) company has deployed its COVID-19 LIMS solution to ensure employee health and safety in the workplace.
-
New £1.3m national research programme to evaluate coronavirus tests
pharmatimes
June 30, 2020
A multicentre national programme of research has been launched to evaluate how new diagnostic tests for COVID-19 perform in hospitals, general practices and care homes, in the hope of making testing quicker, more convenient and more accurate.
-
GenScript Files for EUA of Rapid SARS-CoV-2 Neutralization Antibody Detection Kit
americanpharmaceuticalreview
June 15, 2020
GenScript Biotech announced the company has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to market its cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit.
-
Company develops a COVID-19 test for use on surfaces and wastewater
europeanpharmaceuticalreview
May 26, 2020
IberoGEN has developed a test to detect COVID-19 for use on surfaces and wastewater in the hopes of aiding in the return to normalcy.
-
Manchester Uni researchers develop domestic COVID-19 test
pharmatimes
May 07, 2020
Researchers at Manchester University are working on the development of a test for COVID-19 that could be used at home like a domestic pregnancy test.
-
BARDA Funds Development of Tangen Biosciences’ Multi-Target Platform
contractpharma
May 07, 2020
Also awards Tangen a new contract for Point-of-Care COVID-19 molecular test.
-
CENTOGENE Announces Global Expansion of COVID-19 Testing
americanpharmaceuticalreview
May 06, 2020
CENTOGENE will expand its testing efforts for the novel coronavirus, or COVID-19. The Company was previously testing in Germany’s Mecklenburg-Western Pomerania region.
-
Australia to test COVID-19 vaccine
prnasia
April 15, 2020
The first COVID-19 vaccine to be tested outside of the USA, and only the third vaccine clinical trial in the world, will be conducted by Australia's largest Phase 1 clinical trials specialist Nucleus Network.